Danaher Corp. (NYSE: DHR), Washington, DC, has agreed to acquire Nobel Biocare Holdings LLC for $2.2 billion.
The deal is expected to widen Danaher's market presence in the global dental industry and allow Nobel Biocare to accelerate its strategic objectives and future growth.
Headquartered in Zurich, Switzerland, Nobel Biocare is serves customers in the field of implant-based dental restorations and currently serves customers in 80 markets globally. The company's portfolio includes dental implant systems, high-precision individualized prosthetics, biomaterials and digital diagnostics, treatment planning and guided surgery. In 2013, Nobel Biocare generated annual revenues of EUR 567 million (US$750 million).
Nobel Biocare would become part of Danaher's $2.2 billion dental segment and complements Danaher's position in the implant industry.
"Bringing Nobel Biocare's deep expertise in implant dentistry, digital prosthetics and software together with our extensive knowledge in 3D imaging, intraoral scanning and digital restorative solutions will further enable us to optimize clinical workflows to the benefit of patients and dental practitioners. This combination will help us build a strong platform for future growth," said Henk van Duijnhoven, senior vice president of Danaher's dental segment.
